Results 121 to 130 of about 58,257 (262)

The different face of skin‐rash induced by brentuximab vedotin

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background: Brentuximab vedotin (BV) is a targeted therapy for CD30‐expressing lymphomas, including Hodgkin lymphoma (HL) and cutaneous T‐cell lymphoma (CTCL). While peripheral neuropathy is the most common adverse event, BV‐induced skin rashes are less frequent and not well characterized.
Alessandro Pileri, Tullio Brunetti, Serena Rupoli, Gianluca Cafasso, Corrado Zengarini, Staphano Cedirian, Federico Bardazzi, Cosimo Misciali, Michela Starace, Claudio Agostinelli, Gaia Goteri, Erika Morsia   +11 more
wiley   +1 more source

Consensus‐based Guideline on tinea capitis

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary The consensus‐based guideline developed under the auspices of the German Dermatological Society (DDG) is intended to provide physicians with a structured framework for clinical decision‐making in the management of patients with tinea capitis and to contribute to improved diagnostic accuracy, treatment adherence, and prevention. Tinea capitis is
Peter Mayser, Dietrich Abeck, Philipp P. Bosshard, Jochen Brasch, Georg Daeschlein, Isaak Effendy, Yvonne Gräser, Peter Höger, Julia Huynh, Maria Kinberger, Annette Kolb‐Mäurer, Katharina Antonia Langen, Bartosz Malisiewicz, Alexander Nast, Hagen Ott, Christin Pelzer, Dieter Reinel, Martin Schaller, Silke Uhrlaß, Pietro Nenoff   +19 more
wiley   +1 more source

Real-life Use of Bexarotene for T-cell Cutaneous Lymphoma Management: Efficacy and Tolerance with Low Doses. [PDF]

Acta Derm Venereol, 2022
Rouanet J, Joulie I, Lambert C, D'Incan M.   +3 more
europepmc   +1 more source

Multifocal Indolent CD8+ Cutaneous T-Cell Lymphoma: A Novel Clinicopathologic Entity with Atypical Presentation

EJC Skin Cancer
K. Grafanaki, E. Stefani, K. Lambadaki, V. Pappa, L. Marinos, E. Papadavid   +5 more
doaj   +1 more source

Clinical Warburg Effect in a primary cutaneous lymphoma. [PDF]

Clin Hematol Int
Martins F, Fontinha G, Magalhães J, Cardoso JC, Calvão J.   +4 more
europepmc   +1 more source

Association of Secondary Primary Malignancies in Cutaneous Lymphoma: A Narrative Review. [PDF]

Diagnostics (Basel)
Hung YH, Hsiao PF.
europepmc   +1 more source

Tongue and teeth hyperpigmentation in etoposide, prednisolone, vincristine, and cyclophosphamide regimen in the treatment of cutaneous lymphoma.

Indian J Pharmacol, 2023
Morabad SS, Khan ZU, Gad R, Kallur N, Madhabhavi IV, Shalavadi MH, Mangannavar CV.   +6 more
europepmc   +1 more source

Evaluation of the International Society for Cutaneous Lymphoma Algorithm for the Diagnosis of Early Mycosis Fungoides. [PDF]

Cells, 2021
Ryu HJ, Kim SI, Jang HO, Kim SH, Oh SH, Park S, Kim SK.   +6 more
europepmc   +1 more source

The Role of SAMHD1 in Viral Resistance and Transduction Efficiency Challenges in Pediatric Hematological Malignancies: Mechanistic Insights and Clinical Perspectives

European Journal of Haematology, EarlyView.
SAMHD1 regulates intracellular dNTP pools, influencing lentiviral transduction, gene therapy efficiency, and disease progression in pediatric hematological malignancies. Integrated bioinformatics and targeted strategies, including CRISPR and pharmacological inhibition, highlight its therapeutic potential.
Waseem Alzamzami
wiley   +1 more source

Feline cutaneous lymphoma: an evaluation of disease presentation and factors affecting response to treatment. [PDF]

J Feline Med Surg, 2022
Siewert J, Pellin MA, Husbands BD, Curran KM, Scavelli D, Sampene E.   +5 more
europepmc   +1 more source